Hold Rating Maintained as Solid Momentum Offsets Valuation Concerns; Price Target Trimmed to $110 Amid Medicaid Reform Uncertainty

In a report released yesterday, Sean Dodge from BMO Capital maintained a Hold rating on Addus Homecare, with a price target of $110.00.

Sean Dodge has given his Hold rating due to a combination of factors including solid operating momentum but a more constrained valuation backdrop. He notes that personal care volumes are expanding, supported by technology-enabled productivity and steady hiring, and that recent acquisitions plus a pipeline of larger potential deals should sustain double‑digit EBITDA growth over the medium term.

At the same time, he trims his price target to $110 to reflect multiple compression among peers and acknowledges that ongoing uncertainty around Medicaid reforms continues to weigh on the stock’s valuation. As a result, he sees upside as more balanced against regulatory and reimbursement risks, and indicates he would likely become more positive either if the policy outlook becomes clearer or if the shares retreat to more attractive levels.

According to TipRanks, Dodge is an analyst with an average return of -6.9% and a 39.58% success rate. Dodge covers the Healthcare sector, focusing on stocks such as IQVIA Holdings, Healthequity, and Medpace Holdings.